Mission

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site.... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.

No cookies to display.

Other uncategorised cookies are those that are being analysed and have not been classified into a category as yet.

Mission

While drug discovery is advancing exponentially, drug development is utterly outdated. Until now.

Biotech has never been more innovative. mRNA technology has changed how we make vaccines, CRISPR is rewriting the genome, and there are hundreds of AI drug discovery startups promising to fundamentally transform how we discover new potential medicines.Yet despite this immense innovation, drug development remains stuck in the past.

While research labs and startups buzz with modern tech and AI, drug development trudges along as it did decades ago–manual, fragmented, excruciatingly slow, and unbearably expensive. Surging demand for development resources coupled with growing capacity constraints threaten to stall the very innovations in research that could bring life-saving medicines to patients.

Dash Bio was founded to shatter this barrier.

We are a passionate team of industry veterans with firsthand experience leveraging tech to transform biopharma R&D. We are rebuilding drug development from the ground up with a tech-first approach, leveraging AI, robotics, and fully integrated software to fundamentally reinvent the way drugs are brought to market.

Imagine a world where collaboration with sponsors is intuitive, data flows seamlessly, and bringing a drug to market is faster than ever before. This is the future we’re building.

Our mission is audacious yet simple: to accelerate drug development so that groundbreaking medicines reach those who need them—faster.

Unparalleled quality. Unprecedented speed. Dash Bio.